Is Consolidation Osimertinib Superior in EGFR-Mutated NSCLC? ...Middle East

Medscape - News
A retrospective study showed consolidated osimertinib after chemoradiation prolonged progression-free survival in patients with EGFR-mutated, stage III NSCLC compared with durvalumab or observation. Medscape Medical News

Hence then, the article about is consolidation osimertinib superior in egfr mutated nsclc was published today ( ) and is available on Medscape ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( Is Consolidation Osimertinib Superior in EGFR-Mutated NSCLC? )

Apple Storegoogle play

Last updated :

Also on site :

Most viewed in News


Latest News